https://feeds.newsfilecorp.com/company/12852 Latest news from Matricelf Ltd., as distributed by TMX Newsfile. en CopyRight (c) 2026, Newsfile Corp. All Rights Reserved. office@newsfilecorp.com (Newsfile Corp.) office@newsfilecorp.com (Newsfile Corp.) Thu, 05 Nov 2026 11:34:09 -0500 https://images.newsfilecorp.com/logos/12852.jpg https://feeds.newsfilecorp.com/company/12852 https://www.newsfilecorp.com/release/322724/Matricelf-Reports-Statistically-Significant-Motor-Function-Improvement-in-Preclinical-Efficacy-Study-of-Chronic-Spinal-Cord-Injury 63% of treated animals achieved at least five points of motor function improvement versus 11.5% of controls, representing an approximately 5.5 times higher responder rateStatistically significant motor function benefits demonstrated in both sexes at every assessment from Week 9 through Week 12Ness Ziona, Israel--(Newsfile Corp. - November 5, 2026) - Matricelf Ltd. (TASE: MTLF), a biotechnology company developing personalized engineered neural tissue for spinal cord injury, today announced...<img src="https://api.newsfilecorp.com/newsinfo/322724/156" id="156" width="2" height="2" style="width: 1px; height: 1px;border: 0px solid;" /> Thu, 05 Nov 2026 11:31:00 -0500 en https://www.newsfilecorp.com/release/322724